calendar
4,687 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
4,687 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion
no tagged catalysts yet
Sponsor: Daihong Liu. Phase: PHASE2. Conditions: GVHD, Acute, Stem Cell Transplant Complications
Sponsor: University Hospital Freiburg. Phase: NA. Conditions: Treatment-resistant Depression
Sponsor: MODAG GmbH. Phase: EARLY_PHASE1. Conditions: Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease
Sponsor: Chiang Mai University. Phase: . Conditions: Gestational Diabetes
Sponsor: Mayo Clinic. Phase: NA. Conditions: Insulin Resistance
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE4. Conditions: Rheumatoid Arthritis
Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation, ATM Gene Mutation, PALB2 Gene Mutation
Sponsor: The University of Texas Health Science Center at San Antonio. Phase: . Conditions: Lung Neoplasm
Sponsor: Spaulding Rehabilitation Hospital. Phase: NA. Conditions: Chronic Pain, Carpal Tunnel Syndrome
Sponsor: University of Rochester. Phase: NA. Conditions: Dry Eye Disease (DED)
Sponsor: Claire Bourgeois. Phase: PHASE4. Conditions: Shoulder Pain
Sponsor: Mats Heyman. Phase: PHASE3. Conditions: Leukemia, Acute Lymphoblastic
Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Primary Biliary Cholangitis
Sponsor: The University of Hong Kong. Phase: NA. Conditions: Smoking Cessation, Second Hand Tobacco Smoke
Sponsor: Egas Moniz - Cooperativa de Ensino Superior, CRL. Phase: NA. Conditions: Healthy
Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Substance Use Disorders, Substance Use, Methamphetamine Abuse
Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Surgical Operation With the Settle of a Redon's Drain
Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: . Conditions: Oesophageal Cancer
Sponsor: Neurocrine Biosciences. Phase: PHASE3. Conditions: Schizophrenia
Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Lower Back Pain Chronic
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Healthy Aging
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Hairy Cell Leukemia
Sponsor: University of Applied Sciences for Health Professions Upper Austria. Phase: NA. Conditions: Physical Functional Performance, Physical Education and Training/Methods, Postural Balance, Child
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: GVHD - Graft-Versus-Host Disease, HSCT, Haploidentical Stem Cell Transplantation
Sponsor: Institut Ophtalmologique de l'Ouest Jules Verne. Phase: NA. Conditions: Preoperative Anxiety, Virtual Reality
Sponsor: Institut Bergonié. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer
Sponsor: Metabolics Pharma. Phase: PHASE1. Conditions: Obesity, Diabetes Mellitus, Type 2
Sponsor: Johns Hopkins University. Phase: NA. Conditions: Neuropathic Pain, Chronic Pain
Sponsor: Methodist Health System. Phase: . Conditions: Clinical Outcome of Pericardial Closure Using Gentrix
Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Depressive Sympotoms
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: Central Nervous System Lymphoma
Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: NA. Conditions: CAD
Sponsor: Bout Me Healing. Phase: . Conditions: Substance Use Disorders, Behavioral Health, Addiction Psychological, Addiction Disorders, Meditation, Mindfulness Based Stress Reduction, Prevention
Sponsor: Ceragem Clinical Inc.. Phase: NA. Conditions: Lumbar Disc Herniation, Degenerative Spinal Stenosis, Spine Traction
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Children With Multiple Sclerosis
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Acute Coronary Syndrome, Physical Inactivity
Sponsor: University of Colorado, Denver. Phase: . Conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), T2DM (Type 2 Diabetes Mellitus), T2D, T2DM, Remote Patient Monitoring, Artificial Intelegence
Sponsor: State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital. Phase: NA. Conditions: Parastomal Hernia
Sponsor: University of Alberta. Phase: NA. Conditions: Peripheral Nerve Injuries
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Sensory Science, Performance Assessment, Countermeasure Evaluation, Neurocognitive Function, Psychological Factors
Sponsor: Tanta University. Phase: NA. Conditions: Recto-intercostal Fascial Plane Block, Epigastric Hernia, Analgesia
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: . Conditions: Chronic Kidney Disease
Sponsor: University Hospital, Antwerp. Phase: . Conditions: Postoperative Pain Management, RATS Surgery
Sponsor: Danish Breast Cancer Cooperative Group. Phase: PHASE3. Conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, Luminal B, Her2 Enriched, Basal Like
Sponsor: Singapore General Hospital. Phase: NA. Conditions: Advanced Cancer
Sponsor: Adana City Training and Research Hospital. Phase: NA. Conditions: Back Pain
Sponsor: Microneedle Solutions Ltd. Phase: PHASE4. Conditions: Vaccine Delivery, Tetanus
Sponsor: Maria Cecilia Hospital. Phase: NA. Conditions: Valvular Heart Disease
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS. Phase: . Conditions: Angelman Syndrome
Sponsor: Exelixis. Phase: PHASE1. Conditions: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor, Hepatocellular Carcinoma (HCC), Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Clear Cell Renal Cell Carcinoma (ccRCC), Non-Clear Cell Renal Cell Carcinoma (nccRCC)